Reasons for increased neurite density and reorganization induced by hMSC treatment may be related to the production and parenchymal cell stimulation of neurotrophic factors by hMSCs [41] and increased tissue plasminogen activator (tPA) activity in astrocytes which drives axonal remodeling in hMSC treated stroke animals [5], [42]. Here, PLAT is linked to Stroke.